Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region
Matthew T. Maurano(NYU Langone Health), Adriana Heguy, Carolina Argüelles-Grande(Columbia University Irving Medical Center), Megan S. Hogan(Institute for Systems Biology), Andrew Lytle(Spinal Cord Injury BC), Melissa Call(New York University), Amy Rapkiewicz(New York University), Peter Meyn(Office of Science), Raven D. Luther(Institute for Systems Biology), Nicholas A. Vulpescu(Institute for Systems Biology), Dacia Dimartino(Office of Science), Gael Westby(Office of Science), John Cadley(Institute for Systems Biology), Margaret A. Black(University of Colorado Anschutz Medical Campus), Lawrence Hsu Lin(Harvard University), Marie I. Samanovic(NYU Langone Health), Raquel Ordóñez(Institute for Systems Biology), Sitharam Ramaswami(Office of Science), Antonio E. Serrano(New York University), Emily Huang(Institute for Systems Biology), Jared Pinnell(New York University), Guomiao Shen(NYU Langone Health), Erik Volz(London Centre for Neglected Tropical Disease Research), Christian Marier(Office of Science), Mark J. Mulligan(New York University), Ludovic Boytard(NYU Langone Health), Theodore Vougiouklakis(Memorial Sloan Kettering Cancer Center), Emily Guzman(Office of Science), Xiaojun Feng(Cornell University), George Jour(New York University), Matija Snuderl, Paolo Cotzia(NYU Langone Health), Tatyana Gindin(Columbia University), Iman Osman(New York University), Lily Geidelberg(London Centre for Neglected Tropical Disease Research), Vanessa Raabe(Unknown), Brendan Belovarac(NYU Langone Health), Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), Paul Zappile(New York Genome Center), Min Jae Kim(New York University), Yutong Zhang(Xi’an Jiaotong-Liverpool University), John Chen(Ankara Spine Center), Manon Ragonnet‐Cronin(London Centre for Neglected Tropical Disease Research), André M. Ribeiro-dos-Santos(Institute for Systems Biology), Maria E. Aguero‐Rosenfeld(Apple (Israel))
Cited by 87
Related Papers
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k
Mutations in <i>GNA11</i> in Uveal Melanoma
|New England Journal of Medicine|2010|1.5k
BRAF mutation predicts sensitivity to MEK inhibition
|Nature|2005|1.3k